Drug safety regulators endorse melanoma therapy derived from herpes virus Patients with metastatic melanoma in the United States and Europe are set to have a new treatment option with a therapy derived from the herpes simplex virus.…
FAK inhibitors could allow immune system to attack cancer An experimental inhibitor of the cellular protein focal adhesion kinase helped the immune system to recognise and attack tumours in mice.…
Scientists find another link between aspirin and cancer treatment A study by UK researchers has found a possible explanation for a reported link between aspirin and a reduced risk of cancer.…
Prostate cancer: treatment options When to consider each of the available treatment options for prostate cancer.…
Attacking cancer: are therapeutic vaccines on the verge of fulfilling their potential? Researchers are investigating whether priming the immune system with therapeutic vaccines can prompt the body’s own defences to spring into action against cancer.…
Injection of modified cells reduces inflammation in arthritis sufferers A single injection of a patient’s own modified dendritic cells appears to be safe and to have anti-inflammatory and immunoregulatory effects in rheumatoid arthritis.…
Modified herpes virus therapy shows promise in melanoma A virus-derived oncolytic immunotherapy has shown activity against melanoma in a phase III clinical trial, researchers report in the Journal of Clinical Oncology.…
Ciclosporin fails to demonstrate protection from neuronal damage during thrombolysis The phase II study looked at the potential neuroprotective effect of ciclosporin in 127 stroke patients who also received thrombolysis therapy.…
Combining chemotherapy with immunotherapy is promising treatment for advanced prostate cancer Using mouse models, researchers learn that immune cell manipulation in combination with chemotherapy achieves prostate cancer remission.…
Melanoma therapy that targets PD-1 recommended for EU approvalThe European Medicines Agency has recommended granting a marketing authorisation for new melanoma treatment nivolumab.…
